Carcinogenesis, Vol. 24, No. 1, 113-119,
January 2003
© 2003 Oxford University Press
CARCINOGENESIS |
Simulated sunlight and benzo[a]pyrene diol epoxide induced mutagenesis in the human p53 gene evaluated by the yeast functional assay: lack of correspondence to tumor mutation spectra
1 Department of Biology, Beckman Research Institute of the City of Hope, Duarte, CA, USA and
2 Department of Biochemistry, College of Natural Sciences, Yeungnam University, Kyongsan, 712-749, Korea
Many mutations in the p53 gene destroy the transcriptional transactivation function of the p53 protein. This function of p53 can be determined in a yeast assay using a p53 responsive reporter gene. The yeast assay could hold promise for the identification of mutagens implicated in human cancer if the p53 mutational spectra obtained with this assay would match human tumor mutation data. Ultraviolet (UV) light from the sun and polycyclic aromatic hydrocarbons, such as benzo[a]pyrene, are strongly implicated in the spectrum of p53 mutations found in human non-melanoma skin cancers and smoking-associated lung cancers, respectively. We have used these two model mutagens to assess the feasibility of using the p53 yeast assay in cancer epidemiology. After treatment of CpG methylated p53 DNA with a solar UV simulator or with benzo[a]pyrene diol epoxide (BPDE), the modified p53 sequences were assayed in yeast for mutational outcome. As expected, BPDE produced predominantly G to T transversions and simulated sunlight produced mostly C to T transitions at dipyrimidine sites in the p53 coding sequence. However, the preferentially mutated p53 sequences (hotspots) in the yeast assay were completely different from those in the mutational spectra found in human lung and skin cancers. The data indicate that this assay is not a reliable measurement of p53 mutagenesis in human tissues and that, perhaps, transcriptional activation is not the primary function of p53 in tumor suppression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Liapis, K. I.E. McLuckie, P. D. Lewis, P. B. Farmer, and K. Brown Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots Nucleic Acids Res., October 1, 2008; 36(18): 5933 - 5945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.D. Lewis, B. Manshian, M.N. Routledge, G.B. Scott, and P.A. Burns Comparison of induced and cancer-associated mutational spectra using multivariate data analysis Carcinogenesis, April 1, 2008; 29(4): 772 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. v. Brocke, H. H. Schmeiser, M. Reinbold, and M. Hollstein MEF immortalization to investigate the ins and outs of mutagenesis Carcinogenesis, November 1, 2006; 27(11): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, K.-R. Muehlbauer, H. H. Schmeiser, M. Hergenhahn, D. Belharazem, and M. C. Hollstein p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung Tumors Cancer Res., April 1, 2005; 65(7): 2583 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Valadez and F. P. Guengerich S-(2-Chloroethyl)glutathione-generated p53 Mutation Spectra Are Influenced by Differential Repair Rates More than Sites of Initial DNA Damage J. Biol. Chem., April 2, 2004; 279(14): 13435 - 13446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, M. Hergenhahn, H. H. Schmeiser, G. N. Wogan, A. Hong, and M. Hollstein Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene PNAS, March 2, 2004; 101(9): 2963 - 2968. [Abstract] [Full Text] [PDF]
|
|